Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 19 results.
User Information
Export Records
  1. 1.   Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIV
  2. Vande Woude, S.; Troyer, J.; Poss, M.
  3. Veterinary Immunology and Immunopathology. 2010, Mar; 134(1-2): 25-32.
  1. 2.   Evidence that Productive Human Immunodeficiency Virus Type 1 Assembly Can Occur in an Intracellular Compartment
  2. Joshi, A.; Ablan, S. D.; Soheilian, F.; Nagashima, K.; Freed, E. O.
  3. Journal of Virology. 2009 83(11): 5375-5387.
  1. 3.   GGA and arf proteins modulate retrovirus assembly and release
  2. Joshi, A.; Garg, H.; Nagashima, K.; Bonifacino, J. S.; Freed, E. O.
  3. Molecular Cell. 2008 30(2): 227-238.
  1. 4.   Ty3 capsid mutations reveal early and late functions of the amino-terminal domainv
  2. Larsen, L. S. Z.; Zhang, M.; Beliakova-Bethell, N.; Bilanchone, V.; Lamsa, A.; Nagashima, K.; Najdi, R.; Kosaka, K.; Kovacevic, V.; Cheng, J.; Baldi, P.; Hatfield, G. W.; S, meyer
  3. Journal of Virology. 2007, Jul; 81(13): 6957-6972.
  1. 5.   A second-site suppressor significantly improves the defective phenotype impolsed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein
  2. Tang, S. X.; Ablan, S.; Dueck, M.; Ayala-Lopez, W.; Soto, B.; Caplan, M.; Nagashima, K.; Hewlett, I. K.; Freed, E. O.; Levin, J. G.
  3. Virology. 2007, Mar; 359(1): 105-115.
  1. 6.   Cooperative effect of Gag proteins p12 and capsid during early events of murine leukemia virus replication
  2. Lee, S. K.; Nagashima, K.; Hu, W. S.
  3. Journal of Virology. 2005 79(7): 4159-4169.
  1. 8.   Late domain-dependent inhibition of equine infectious anemia virus budding
  2. Miranda, S. X.; Ablan, S.; Demirov, D. G.; Chen, C. P.; Montelaro, R. C.; Freed, E. O.
  3. Journal of Virology. 2004 78(2): 724-732.
  1. 9.   Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles
  2. Trubey, C. M.; Chertova, E.; Coren, L. V.; Hilburn, J. M.; Hixson, C. V.; Nagashima, K.; Lifson, J. D.; Ott, D. E.
  3. Journal of Virology. 2003 77(23): 12699-12709.
  1. 10.   Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant
  2. Ott, D. E.; Coren, L. V.; Chertova, E. N.; Gagliardi, T. D.; Nagashima, K.; Sowder, R. C.; Poon, D. T. K.; Gorelick, R. J.
  3. Journal of Virology. 2003 77(10): 5547-5556.
  1. 11.   Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells
  2. Tang, S. X.; Murakami, T.; Agresta, B. E.; Campbell, S.; Freed, E. O.; Levin, J. G.
  3. Journal of Virology. 2001 75(19): 9357-9366.
  1. 12.   A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions
  2. Gupta, K.; Ott, D.; Hope, T. J.; Siliciano, R. F.; Boeke, J. D.
  3. Journal of Virology. 2000 74(24): 11811-11824.
  1. 13.   Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: Stimulation by the viral nucleocapsid protein
  2. Carteau, S.; Gorelick, R. J.; Bushman, F. D.
  3. Journal of Virology. 1999 73(8): 6670-6679.
  1. 14.   Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein
  2. Ott, D. E.; Chertova, E. N.; Busch, L. K.; Coren, L. V.; Gagliardi, T. D.; Johnson, D. G.
  3. Journal of Virology. 1999 73(1): 19-28.
  1. 15.   Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates
  2. Tozser, J.; Bagossi, P.; Boross, P.; Louis, J. M.; Majerova, E.; Oroszlan, S.; Copeland, T. D.
  3. European Journal of Biochemistry. 1999 265(1): 423-429.
  1. 16.   Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin
  2. Liu, B. D.; Dai, R. K.; Tian, C. J.; Dawson, L.; Gorelick, R.; Yu, X. F.
  3. Journal of Virology. 1999 73(4): 2901-2908.
  1. 17.   Ubiquitin Is Covalently Attached to the P6(Gag) Proteins of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus and to the P12(Gag) Protein of Moloney Murine Leukemia Virus
  2. Ott, D. E.; Coren, L. V.; Copeland, T. D.; Kane, B. P.; Johnson, D. G.; Sowder, R. C.; Yoshinaka, Y.; Oroszlan, S.; Arthur, L. O.; Henderson, L. E.
  3. Journal of Virology. 1998 72(4): 2962-2968.
  1. 18.   Inhibition of Multiple Phases of Human Immunodeficiency Virus Type 1 Replication By a Dithiane Compound That Attacks the Conserved Zinc Fingers of Retroviral Nucleocapsid Proteins
  2. Rice, W. G.; Baker, D. C.; Schaeffer, C. A.; Graham, L.; Bu, M.; Terpening, S.; Clanton, D.; Schultz, R.; Bader, J. P.; Buckheit, R. W.; Field, L.; Singh, P. K.; Turpin, J. A.
  3. Antimicrobial Agents and Chemotherapy. 1997 41(2): 419-426.
  1. 19.   Zinc Ejection As a New Rationale For the Use of Cystamine and Related Disulfide-Containing Antiviral Agents in the Treatment of Aids
  2. McDonnell, N. B.; Deguzman, R. N.; Rice, W. G.; Turpin, J. A.; Summers, M. F.
  3. Journal of Medicinal Chemistry. 1997 40(13): 1969-1976.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel